Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock

LIMN
Liminatus Pharma, Inc. Class A Common StockUS flagNASDAQ Global Select
3.71
USD
+0.01
- -
4.98MMarket Cap

Liminatus Pharma, Inc. Class A Common Stock (LIMN) Stock Split History

Learn about Liminatus Pharma, Inc. Class A Common Stock's most recent 1-for-50 basis stock split on August 21, 2026. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Liminatus Pharma, Inc. Class A Common Stock's most recent stock split

Split Date: 2026-08-21
Split Ratio: 1:50
Price Before Split: $0.10
Price After Split: $0.00

Developer API

Get LIMN split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/LIMN

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 50.00 times fewer shares (a 1:50 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Liminatus Pharma, Inc. Class A Common Stock's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-08-211:50Yes$0.10$0.00

About Liminatus Pharma, Inc. Class A Common Stock

Company overview and industry information

Liminatus Pharma, Inc. Class A Common Stock (LIMN) operates in the Biotechnology industry. The recent 1-for-50 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Liminatus Pharma, Inc. Class A Common Stock Summary

Last updated: 9/5/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.